These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 34425325)
1. Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatment. Gowin K; Skerget S; Keats JJ; Mikhael J; Cowan AJ Leuk Res; 2021 Dec; 111():106687. PubMed ID: 34425325 [TBL] [Abstract][Full Text] [Related]
2. The Current State of Knowledge About Evolution of Multiple Myeloma to Plasma Cell Leukemia. Jurczyszyn A; Olszewska-Szopa M; Vesole DH Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):188-193. PubMed ID: 36593169 [TBL] [Abstract][Full Text] [Related]
3. [Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis]. Jurczyszyn A; Zawirska D; Skotnicki AB Przegl Lek; 2011; 68(6):320-5. PubMed ID: 22039670 [TBL] [Abstract][Full Text] [Related]
4. Plasma cell leukemia: update on biology and therapy. Mina R; D'Agostino M; Cerrato C; Gay F; Palumbo A Leuk Lymphoma; 2017 Jul; 58(7):1538-1547. PubMed ID: 27819179 [TBL] [Abstract][Full Text] [Related]
6. Plasma cell leukemia: concepts and management. Liedtke M; Medeiros BC Expert Rev Hematol; 2010 Oct; 3(5):543-9. PubMed ID: 21083471 [TBL] [Abstract][Full Text] [Related]
7. A clinical perspective on plasma cell leukemia; current status and future directions. Tuazon SA; Holmberg LA; Nadeem O; Richardson PG Blood Cancer J; 2021 Feb; 11(2):23. PubMed ID: 33563906 [TBL] [Abstract][Full Text] [Related]
8. An update on biology, diagnosis and treatment of primary plasma cell leukemia. Musto P; Statuto T; Valvano L; Grieco V; Nozza F; Vona G; Bochicchio GB; La Rocca F; D'Auria F Expert Rev Hematol; 2019 Apr; 12(4):245-253. PubMed ID: 30905220 [TBL] [Abstract][Full Text] [Related]
9. Plasma Cell Leukemia – the Forgotten Disease. Žárska M; Vrábel D; Bezdekova R; Štork M; Jarošová M; Adam Z; Krejčí M; Pour L; Ševčíková S Klin Onkol; 2019; 32(1):40-46. PubMed ID: 30764628 [TBL] [Abstract][Full Text] [Related]
10. Current Status on Management of Primary Plasma Cell Leukemia. Gong Z; Khosla M; Vasudevan S; Mohan M Curr Oncol Rep; 2024 Sep; 26(9):1104-1112. PubMed ID: 38954316 [TBL] [Abstract][Full Text] [Related]
11. How We Manage Newly Diagnosed Multiple Myeloma With Circulating Tumor Cells. van de Donk NWCJ J Clin Oncol; 2023 Mar; 41(7):1342-1349. PubMed ID: 36450104 [No Abstract] [Full Text] [Related]
12. Plasma cell leukemia--a case report. Badhe BA; Basu D; Toi PCh; Dutta TK; Ghotekar LH Indian J Pathol Microbiol; 2003 Jul; 46(3):484-7. PubMed ID: 15025318 [TBL] [Abstract][Full Text] [Related]
13. Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision Medicine. Simeon V; Todoerti K; La Rocca F; Caivano A; Trino S; Lionetti M; Agnelli L; De Luca L; Laurenzana I; Neri A; Musto P Int J Mol Sci; 2015 Jul; 16(8):17514-34. PubMed ID: 26263974 [TBL] [Abstract][Full Text] [Related]
14. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Fernández de Larrea C; Kyle RA; Durie BG; Ludwig H; Usmani S; Vesole DH; Hajek R; San Miguel JF; Sezer O; Sonneveld P; Kumar SK; Mahindra A; Comenzo R; Palumbo A; Mazumber A; Anderson KC; Richardson PG; Badros AZ; Caers J; Cavo M; LeLeu X; Dimopoulos MA; Chim CS; Schots R; Noeul A; Fantl D; Mellqvist UH; Landgren O; Chanan-Khan A; Moreau P; Fonseca R; Merlini G; Lahuerta JJ; Bladé J; Orlowski RZ; Shah JJ; Leukemia; 2013 Apr; 27(4):780-91. PubMed ID: 23288300 [TBL] [Abstract][Full Text] [Related]
15. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature. Gangadhar P; Ahmed Z; Pai MR; Sandhya I Indian J Pathol Microbiol; 2016; 59(4):541-544. PubMed ID: 27721294 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome. Todoerti K; Agnelli L; Fabris S; Lionetti M; Tuana G; Mosca L; Lombardi L; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Omede' P; Tassone P; Boccadoro M; Palumbo A; Neri A; Musto P Clin Cancer Res; 2013 Jun; 19(12):3247-58. PubMed ID: 23599371 [TBL] [Abstract][Full Text] [Related]
17. [Advances in the Diagnosis and Therapy of Primary Plasma Cell Leukemia -Review]. Wang H; Li JY; Sun C; Zhou X Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1837-1841. PubMed ID: 29262927 [TBL] [Abstract][Full Text] [Related]
18. Primary plasma cell leukemia 2.0: advances in biology and clinical management. Neri A; Todoerti K; Lionetti M; Simeon V; Barbieri M; Nozza F; Vona G; Pompa A; Baldini L; Musto P Expert Rev Hematol; 2016 Nov; 9(11):1063-1073. PubMed ID: 27759436 [TBL] [Abstract][Full Text] [Related]